This protein is an intramembrane aspartyl protease that takes part in several important biological processes, most notably the cleavage of specific single-pass transmembrane proteins. SPPL2a is implicated in cellular pathways associated with immune response, intracellular signaling, and possibly metabolic regulation. The activators for SPPL2a are a chemically heterogeneous group, sourced from a variety of origins including natural plant extracts, endogenous hormones, and synthetic molecules. These compounds exert their effects through diverse biochemical pathways, including the activation of cellular signaling mechanisms such as Mitogen-Activated Protein Kinase (MAPK), cyclic Adenosine Monophosphate (cAMP), and Wnt signaling pathways. ctivators targeting SPPL2a come from multiple chemical classes and origins, including natural compounds found in plants, synthetic small molecules designed in laboratories, and endogenous substances like certain hormones.
Their biochemical mechanisms of action are equally varied and include interactions with specific receptors, modulation of key cellular signaling pathways like the Mitogen-Activated Protein Kinase (MAPK) and cyclic Adenosine Monophosphate (cAMP), and alterations in intracellular calcium levels, among other routes. Chemically, SPPL2a activators can be quite varied, encompassing a broad range of molecular weights, solubilities, and chemical structures. For example, some may be small and lipophilic, easily crossing cell membranes, while others might be larger, polar molecules that act by binding to specific cellular receptors. The biochemical routes by which these activators function are equally diverse; some might directly interact with transcription factors to induce SPPL2a expression, while others might activate a cascade of intracellular events that eventually leads to upregulation. Despite this diversity, what unites them is their ability to modulate SPPL2a in some form, providing invaluable tools for researchers interested in understanding the intricate details of SPPL2a function and regulation.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin activates the MAPK signaling pathway, which could potentially upregulate SPPL2a expression. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is known to activate Protein Kinase C (PKC), potentially leading to the induction of SPPL2a. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Sodium butyrate is a histone deacetylase (HDAC) inhibitor and may enhance SPPL2a expression by altering chromatin structure. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin may activate the cAMP signaling pathway, potentially leading to the upregulation of SPPL2a. | ||||||
Lipopolysaccharide, E. coli O55:B5 | 93572-42-0 | sc-221855 sc-221855A sc-221855B sc-221855C | 10 mg 25 mg 100 mg 500 mg | $98.00 $171.00 $425.00 $1560.00 | 12 | |
LPS is known to activate the TLR4 signaling pathway, which might lead to the induction of SPPL2a in immune cells. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol activates beta-adrenergic receptors and may induce SPPL2a through cAMP-dependent pathways. | ||||||
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $156.00 $1248.00 $12508.00 | 82 | |
Insulin could potentially induce SPPL2a expression via activation of the insulin receptor and downstream signaling pathways. | ||||||
Betamethasone Valerate | 2152-44-5 | sc-204649 sc-204649A | 100 mg 500 mg | $195.00 $670.00 | ||
TNF-alpha activates NF-kappaB and may upregulate SPPL2a expression as part of immune response modulation. | ||||||
Thymosin β4 | 77591-33-4 | sc-396076 sc-396076A | 1 mg 100 mg | $134.00 $7140.00 | ||
TGF-beta activates the SMAD signaling pathway and may play a role in inducing the expression of SPPL2a. | ||||||